{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T17:05:00Z","timestamp":1765731900641},"reference-count":49,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2009,7,2]],"date-time":"2009-07-02T00:00:00Z","timestamp":1246492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Prescription of proton pump inhibitors (PPIs) has increased dramatically.<\/jats:p><jats:p><jats:bold>Aim\u2002<\/jats:bold> To assess therapeutic intent of PPI prescription among elderly veterans prescribed nonsteroidal anti\u2010inflammatory drugs.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Medical\u2010record abstraction identified therapeutic intent of PPI prescription. An \u2018appropriate therapeutic intent\u2019 was defined as symptomatic gastro\u2010oesophageal reflux disease or endoscopic oesophagitis, Zollinger\u2013Ellison disease, dyspepsia, upper gastrointestinal event, <jats:italic>Helicobacter pylori<\/jats:italic> infection or nonsteroidal anti\u2010inflammatory drug gastroprotection. Logistic regression predicted the outcome while adjusting for clinical characteristics.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Of 1491 patients [mean 73\u2003years (s.d. 5.6), 73% white and 99.8% men], among those charts which did document a therapeutic indication, 88.8% were appropriate. Prior gastroscopy was predictive of an appropriate therapeutic intent (OR 2.7; 95% CI: 1.9\u20133.7). Prescription to patients who used VA pharmacy services only, to in\u2010patients, or by a cardiologist or an otolaryngologist were less likely to be appropriate. Gastroprotection was poorly recognized as an indication for PPI prescription, except by rheumatologists (OR 46.7; 95% CI: 15.9\u2013136.9), or among highly co\u2010morbid patients (OR 1.8; 95% CI: 1.1\u20132.9). Among in\u2010patients, 45% of PPI prescriptions were initiated for unknown or inappropriate reasons.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Type of provider predicts appropriate PPI use. In\u2010patient prescription is associated with poor recognition of necessary gastroprotection and unknown therapeutic intent.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2009.04085.x","type":"journal-article","created":{"date-parts":[[2009,7,2]],"date-time":"2009-07-02T05:39:06Z","timestamp":1246513146000},"page":"652-661","source":"Crossref","is-referenced-by-count":17,"title":["Therapeutic intent of proton pump inhibitor prescription among elderly nonsteroidal anti\u2010inflammatory drug users"],"prefix":"10.1111","volume":"30","author":[{"given":"A. M.","family":"DRIES","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"RICHARDSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"CAVAZOS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. S.","family":"ABRAHAM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,8,18]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.08.018"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00723.x"},{"key":"e_1_2_6_4_2","unstructured":"IMS Health Inc.IMS National Sales Perspectives \u2013 TM.2005[cited March 2006]. Available at:http:\/\/www.imshealth.com\/ims\/portal\/front\/articleC\/0 2777 6599_3665_69890098 00.html"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.16.1955"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.23.2989"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.24.2947"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0953-0673.2004.01840.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0269-2813.2004.01834.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.08.003"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10425"},{"issue":"3","key":"e_1_2_6_12_2","first-page":"iii23","article-title":"Underutilization of preventive strategies in patients receiving NSAIDs","volume":"42","author":"Sturkenboom MC","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","first-page":"S412","DOI":"10.14309\/00000434-200609001-01048","article-title":"Outcomes of provider adherence to NSAID prescription guidelines","volume":"101","author":"Abraham NS","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.08.016"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02985.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(88)90162-X"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68932-0"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1053\/bega.2001.0192"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07272-0"},{"issue":"2","key":"e_1_2_6_20_2","first-page":"A105","article-title":"Proton pump inhibitor plus a COX\u20102 inhibitor for the prevention of recurrent ulcer bleeding in patients with arthritis: a double\u2010blind, randomized trial","volume":"130","author":"Chan FK","year":"2006","journal-title":"Gastroenterology"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198901123200201"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.30272.x"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2004.01808.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200008033430501"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.09.019"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199912000-00034"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200206001-00005"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200103293441304"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1159\/000089727"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02810.x"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.317.7156.452"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03226.x"},{"key":"e_1_2_6_33_2","first-page":"24","article-title":"The prevalence of proton pump inhibitor use in hospitalized patients","volume":"29","author":"Gingold AR","year":"2006","journal-title":"Practical Gastroenterology"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2004.00298.x"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2000.00312.x"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2000.tb123871.x"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199205000-00001"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.1997.012004247.x"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1177\/1077558703060002007"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1497.2005.40135.x"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.1.8"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G703"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-006-9028-4"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-200112000-00013"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2004.03.037"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03213.x"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00844.x"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-200201000-00007"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1136\/tc.9.4.382"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/57.4.M223"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2009.04085.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2009.04085.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T20:08:19Z","timestamp":1697227699000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2009.04085.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,18]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1111\/j.1365-2036.2009.04085.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2009.04085.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,18]]}}}